Literature DB >> 16361839

Dialysis patients and cardiovascular problems: Can technology help solve the complex equation?

Claudio Ronco1, Sudhi Bowry, Ciro Tetta.   

Abstract

Patients with end-stage kidney disease undergoing chronic hemodialysis (HD) present higher mortality rates compared with the general population. Once patients are on HD, the risk of cardiovascular death is approximately 30 times higher than in the general population and remains 10-20 times higher after stratification for age, gender, and the presence of diabetes. About half the deaths of patients on dialysis are attributed to cardiovascular causes including coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The cardiovascular burden of the HD patient arises from three different sources: risks inherent to the patient and the uremic syndrome, traditional risk factors, and risk factors related to the dialysis therapy. Based on these considerations and the fact that several aspects of the dialysis procedure can either add to the cardiovascular burden or modify the existing burden, new technologies should be directed towards the approach of a potential 'cardioprotective dialysis therapy'; such an approach may be facilitated by the application of new techniques and advanced dialysis machines. Created to make dialysis easy and safe, new machines feature several options that make patient monitoring and online hemodiafiltration therapy routine procedures. These and other features will possibly make dialysis better tolerated and more efficient in protecting patients from undesirable or potentially fatal cardiovascular events. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16361839     DOI: 10.1159/000089435

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

1.  Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.

Authors:  Vera Krane; Mario Berger; Jürgen Lilienthal; Karl Winkler; Christian Schambeck; Christoph Wanner
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

Review 2.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

3.  Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis.

Authors:  Valdete Topciu Shufta; Luljeta Begolli; Emrush Kryeziu
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

Review 4.  The scientific principles and technological determinants of haemodialysis membranes.

Authors:  Sudhir K Bowry; Charles Chazot
Journal:  Clin Kidney J       Date:  2021-12-27

Review 5.  Multitargeted interventions to reduce dialysis-induced systemic stress.

Authors:  Bernard Canaud; Melanie P Stephens; Milind Nikam; Michael Etter; Allan Collins
Journal:  Clin Kidney J       Date:  2021-12-27

Review 6.  Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation.

Authors:  Sudhir K Bowry; Fatih Kircelli; Rainer Himmele; Sagar U Nigwekar
Journal:  Clin Kidney J       Date:  2021-12-27

7.  Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities.

Authors:  Bernard Canaud; Charles Chazot; Jeroen Koomans; Allan Collins
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.